Green Health & Wellness MoonLake Immunotherapeutics explores sale – Reuters News Agency – GWC Mag gwcmagOctober 3, 2023040 views Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday, giving the company a market value of $3.3 billion. Article Tags Topics of Interest: Business & FinanceDealsHealth Type: Reuters Best Sectors: Business & FinancePharmaceuticals & Healthcare Regions: Europe Countries: Switzerland Win Types: Exclusivity Story Types: Exclusive / Scoop Media Types: Text Customer Impact: Significant National Story